| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:50 UTC |
|---|
| HMDB ID | HMDB0015037 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Didanosine |
|---|
| Description | A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. [PubChem] |
|---|
| Structure | OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 2,3-Dideoxyinosine | ChEBI | | 9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one | ChEBI | | 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one | ChEBI | | 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol | ChEBI | | 9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one | ChEBI | | DDI | ChEBI | | DdIno | ChEBI | | Didanosina | ChEBI | | Didanosinum | ChEBI | | Dideoxyinosine | ChEBI | | Videx | Kegg | | ABBR ddi | Kegg | | 2',3' Dideoxyinosine | HMDB | | Bristol-myers brand OF didanosine | HMDB | | DdI (antiviral) | HMDB | | Bristol myers squibb brand OF didanosine | HMDB | | 2',3'-Dideoxyinosine | HMDB | | Bristol myers brand OF didanosine | HMDB | | Bristol-myers squibb brand OF didanosine | HMDB |
|
|---|
| Chemical Formula | C10H12N4O3 |
|---|
| Average Molecular Weight | 236.2273 |
|---|
| Monoisotopic Molecular Weight | 236.09094027 |
|---|
| IUPAC Name | 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one |
|---|
| Traditional Name | didanosine |
|---|
| CAS Registry Number | 69655-05-6 |
|---|
| SMILES | OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O |
|---|
| InChI Identifier | InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1 |
|---|
| InChI Key | BXZVVICBKDXVGW-NKWVEPMBSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as purine 2',3'-dideoxyribonucleosides. Purine 2',3'-dideoxyribonucleosides are compounds consisting of a purine linked to a ribose which lacks a hydroxyl group at positions 2 and 3. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | Purine nucleosides |
|---|
| Sub Class | Purine 2',3'-dideoxyribonucleosides |
|---|
| Direct Parent | Purine 2',3'-dideoxyribonucleosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Purine 2',3'-dideoxyribonucleoside
- 6-oxopurine
- Hypoxanthine
- Purinone
- Imidazopyrimidine
- Purine
- Pyrimidone
- N-substituted imidazole
- Pyrimidine
- Heteroaromatic compound
- Azole
- Imidazole
- Tetrahydrofuran
- Vinylogous amide
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Alcohol
- Organopnictogen compound
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic oxide
- Hydrocarbon derivative
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 160 - 163 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 6.58 g/L | Not Available | | LogP | -0.2 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.32 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.8921 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.29 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 35.7 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1450.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 262.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 107.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 95.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 299.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 313.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 113.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 683.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 319.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1027.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 224.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 212.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 451.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 166.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 94.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Didanosine,1TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2[NH]C=NC3=O)O1 | 2317.4 | Semi standard non polar | 33892256 | | Didanosine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC(=O)C2=C1N([C@H]1CC[C@@H](CO)O1)C=N2 | 2448.2 | Semi standard non polar | 33892256 | | Didanosine,2TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2N([Si](C)(C)C)C=NC3=O)O1 | 2428.1 | Semi standard non polar | 33892256 | | Didanosine,2TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2N([Si](C)(C)C)C=NC3=O)O1 | 2603.7 | Standard non polar | 33892256 | | Didanosine,2TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2N([Si](C)(C)C)C=NC3=O)O1 | 3273.0 | Standard polar | 33892256 | | Didanosine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2[NH]C=NC3=O)O1 | 2542.5 | Semi standard non polar | 33892256 | | Didanosine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC(=O)C2=C1N([C@H]1CC[C@@H](CO)O1)C=N2 | 2665.6 | Semi standard non polar | 33892256 | | Didanosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)O1 | 2818.3 | Semi standard non polar | 33892256 | | Didanosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)O1 | 3019.2 | Standard non polar | 33892256 | | Didanosine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1CC[C@H](N2C=NC3=C2N([Si](C)(C)C(C)(C)C)C=NC3=O)O1 | 3321.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Didanosine GC-MS (Non-derivatized) - 70eV, Positive | splash10-056u-9670000000-b8e1fdd18fda2c412cef | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Didanosine GC-MS (1 TMS) - 70eV, Positive | splash10-005c-7090000000-ed6dc7eca7c11c73693a | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Didanosine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Didanosine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , negative-QTOF | splash10-000i-0090000000-fed0a8ffc5839fe73fe1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , negative-QTOF | splash10-000i-0490000000-0ac04c4f4e817e6da391 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , negative-QTOF | splash10-000i-0920000000-14a23956c10d3f6e7e9a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , negative-QTOF | splash10-000i-0900000000-de4599cfceaa46089291 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , negative-QTOF | splash10-000i-1900000000-10d07c81e3fc72fcfef2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , negative-QTOF | splash10-000i-1900000000-84e8bb1bea77e6b5bfca | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , positive-QTOF | splash10-000i-0900000000-6a0516d1b3cec255e050 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , positive-QTOF | splash10-000i-0900000000-fd0dfb766f1c628d170d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , positive-QTOF | splash10-000i-0900000000-3d9e0ecfaf77d867a9d9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , positive-QTOF | splash10-000i-0900000000-e0e7d0c808e14d842dbb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , positive-QTOF | splash10-000i-1900000000-9d4b77c3e99e9f9a2c2a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine LC-ESI-QFT , positive-QTOF | splash10-000i-1900000000-2bb63f71ec2e92ce075d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 90V, Negative-QTOF | splash10-000i-1900000000-1475736d859ee324d92e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 75V, Negative-QTOF | splash10-000i-0900000000-2cd1a2d12ed969154415 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 45V, Negative-QTOF | splash10-000i-0920000000-410013d0d67e872eea6b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 60V, Negative-QTOF | splash10-000i-0900000000-544cf7886920f267da7a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 45V, Positive-QTOF | splash10-000i-0900000000-74008fe84aaa4adb23ed | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 60V, Positive-QTOF | splash10-000i-0900000000-532725f06bed9d035dcf | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Didanosine 90V, Positive-QTOF | splash10-000i-1900000000-7d5a4e68524522f15eca | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Didanosine 10V, Positive-QTOF | splash10-000i-0920000000-a89fd678ed8a8c16accc | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Didanosine 20V, Positive-QTOF | splash10-000i-0900000000-a1a5b268d419fff83602 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Didanosine 40V, Positive-QTOF | splash10-03dr-1900000000-32bbc23c752210d7cd6f | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Didanosine 10V, Negative-QTOF | splash10-000i-0190000000-383b44cf919dd28ff3bb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Didanosine 20V, Negative-QTOF | splash10-000i-2940000000-309e7293be866f0e29aa | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Didanosine 40V, Negative-QTOF | splash10-052u-3900000000-0828603c96a200af867a | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|